Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease-Reference-Cited by-同舟云学术

Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease

Published:2024-03 Issue: Volume:268 Page:116263
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Amblard Franck,LeCher Julia C.,De Ramyani,Zhou Shaoman,Liu Peng,Goh Shu Ling,Tao Sijia,Patel Dharmeshkumar,Downs-Bowen Jessica,Zandi Keivan,Zhang Huanchun,Chaudhry Gitika,McBrayer Tamara,Muczynski Michael,Al-Homoudi Abdullah,Engel Joseph,Lan Shuiyun,Sarafianos Stefan G.,Kovari Ladislau C.,Schinazi Raymond F.

Funder

National Institutes of Health

Publisher

Elsevier BV

Reference47 articles.

1. Evolution of the SARS-CoV-2 genome and emergence of variants of concern;Safari;Arch. Virol.,2022

2. Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19;Boras;Nat. Commun.,2021

3. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review;Li;Eur. J. Med. Chem.,2023

4. The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022;Pang;Eur. J. Med. Chem.,2023

5. Discovery of PF-07817883: A Next Generation Oral Protease Inhibitor for the Treatment of COVID-19;Tuttle,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries;Antimicrobial Agents and Chemotherapy;2024-08-28

2. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries;2024-03-18